Riskpilot← Back to searchSign inGet full accessEarWise AB
ABActiveOrg 5591710040Nedre Fogelbergsgatan 4 AWholesale of pharmaceutical and medical goods · NACE 4646Est. 20182 employees
Revenue 2025
SEK 5,3M
-19% vs 2024
EBITDA margin
8.1%
-29% vs 2024
Equity ratio
52.5%
Financial strength
Net profit 2025
SEK 319K
-27% vs 2024
| Revenue | SEK 5,3M | -19% |
| EBITDA | SEK 427K | -29% |
| Net profit | SEK 319K | -27% |
| Total assets | SEK 1,4M | -20% |
| Equity | SEK 756K | -18% |
| Employees | 2 | — |
Legal name
EarWise AB
Org number
5591710040
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
11 september 2018
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva hörselvård, försäljning av hörselskydd, hörapparater, tekniska hjälpmedel och tillbehör samt därmed förenlig verksamhet
Address
Nedre Fogelbergsgatan 4 A
Phone
+46313204244
Email
hej@earwise.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 250 | 3 234 | 4 926 | 6 483 | 5 268 |
| Staff expenses | — | −963 | −1 378 | −1 672 | −1 658 |
| EBITDA | 32 | 229 | 420 | 599 | 427 |
| Depreciation & amort. | −38 | −44 | −44 | −48 | −25 |
| EBIT | −6 | 185 | 376 | 551 | 403 |
| Net financials | −2 | −2 | 1 | −1 | −2 |
| Profit before tax | −8 | 183 | 377 | 550 | 401 |
| Tax | −0 | −37 | −84 | −114 | −82 |
| Net profit | −8 | 146 | 293 | 436 | 319 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 625 | 946 | 1 165 | 1 791 | 1 439 |
| Equity | 292 | 438 | 732 | 917 | 756 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 333 | 508 | 434 | 873 | 683 |
| Total debt | 333 | 508 | 434 | 873 | 683 |
EBITDA margin
8.1%
This company
15.8%
Market median
-49% vs market
20212025
Equity ratio
52.5%
This company
38.2%
Market median
+37% vs market
20212025
Return on equity
42.1%
This company
18.4%
Market median
+129% vs market
20212025
Net profit margin
6.0%
This company
8.1%
Market median
-26% vs market
20212025
Asset turnover
3.66×
This company
1.12×
Market median
+227% vs market
20212025
Debt / equity
0.90×
This company
0.62×
Market median
+45% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Chairman | 2022 | |
| Deputy Board Member | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of EarWise AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Göran Ingvar Torpheimer | Deputy Board Member | 0 companies |
| Daniel Erik Love Allde | Board of Directors | 0 companies |
| Astrid Eeva Katarina Allde | Deputy Board Member | 0 companies |
| Henrik Carl Tore Svensson | Chairman | 0 companies |
| Ing-Marie Birgitta Svensson | Deputy Board Member | 0 companies |